QUINTA-ANALYTICA
Lia Martinez-Montero is currently the Director of Business Development at Conscio Group, which includes companies like GEN PLUS, QUINTA ANALYTICA, EL, and LVA. They offer various services for the pharmaceutical industry, including lead optimization, formulation development, clinical testing, and GMP testing. Prior to this role, Lia worked as the Director of Business Development at Gen-Plus GmbH & Co. KG, where they focused on innovative formulation services and IMP manufacturing. They also have experience as the Business Development Manager Biotechnology at Clariant and as a Biocatalytic Project Manager at Teva Pharmaceuticals. Lia has a strong academic background, having been a Postdoctoral Research Fellow at Karl-Franzens-Universität Graz, BIOMIN, and Universidad de Oviedo. They also have experience as a Ph.D. Student at Universidad de Oviedo, where they specialized in biocatalysis, biochemistry, and organic chemistry. Additionally, Lia has gained international experience as an Exchange Graduate Student at Technische Universiteit Delft and Universiteit van Amsterdam.
Lia Martinez-Montero completed their education in a sequential manner. Lia acquired a Bachelor's degree in Organic Chemistry from Universidad de Oviedo between 2007 and 2012. Following this, Lia pursued a Master's degree in Organic Chemistry and Medicinal Chemistry at the same university from 2012 to 2013. Lia then continued their studies at Universidad de Oviedo, obtaining a Doctor of Philosophy (PhD) in Enzyme Technology and Protein Chemistry from 2013 to 2017. Afterward, Lia conducted postdoctoral research as a fellow at Karl-Franzens-Universität Graz from 2018 to 2019, focusing on Chemistry and Biotechnology. Additionally, the information provided does not indicate any specific degree or field of study for the incomplete education at Delft University of Technology and the University of Amsterdam.
This person is not in any offices
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.